[HTML][HTML] Recent Advances in the Molecular Biology of Chronic Lymphocytic Leukemia: How to Define Prognosis and Guide Treatment
A Arcari, L Morello, E Borotti, E Ronda, A Rossi… - …, 2024 - pmc.ncbi.nlm.nih.gov
Simple Summary The therapeutic landscape of Chronic Lymphocytic Leukemia (CLL) has
dramatically changed in recent years, with a shift from chemoimmunotherapy towards many …
dramatically changed in recent years, with a shift from chemoimmunotherapy towards many …
[PDF][PDF] Rethinking the reimbursement of innovative medicines in oncology: Looking beyond overall survival
The oncological treatment landscape is evolving at a very rapid pace with a continuous
stream of novel treatment options. To fully leverage these therapeutic advances in clinical …
stream of novel treatment options. To fully leverage these therapeutic advances in clinical …
Association of CYP1A1 T3801C (rs4646903) variant with the susceptibility and progression of B-chronic lymphocytic Leukemia (B-CLL) in the Egyptian population
Background The frequency of hematological malignancies is increasing universally, and
over the last few decades, a significant increase in the incidence of B-chronic lymphocytic …
over the last few decades, a significant increase in the incidence of B-chronic lymphocytic …